To get a better understanding of the bioanalytical applications of chromatography we interviewed Makoto Tsunoda (University of Tokyo, Japan). Makoto described his research developing analytical methods to quantify endogenous compounds in a range of complex matrices.
We talked to Joseph Pesek (Professor Emeritus, San José State University, CA, USA) about his research developing novel stationary phases. Joe told us what which stationary phases he’s excited to see develop and gave us some tips for best practice.
Jihua Chen (Regeneron, NY, USA) author of ‘Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pH’ published in Bioanalysis gives us an insight into his research and some of the major challenges in the field.
In this interview Sanyogitta Puri, Associate Director (AstraZeneca, Cambridge, UK), explores AstraZeneca’s involvement in the cell and gene therapy field.
As we enter 2020, Bioanalysis Zone cast a reflective eye over another exciting year in the bioanalytical field. In this editorial we breakdown the year into the ABCs of bioanalysis, covering the top interviews, news, discussion and conferences that 2019 had to offer.
Uma Kavita (Bristol-Myers Squibb, NJ, USA) discusses lipid nanoparticle drug products and explains the importance of immunogenicity assessments as well as some of the challenges with current regulatory guidance.
In this interview, Mark Bayliss (North Bristol NHS Trust, Southmead Hospital; Bristol, UK) discusses his bioanalytical career and explores the importance of bioanalysis through observations in made in his current research.
In this interview, Richard Kay (Wellcome Trust, University of Cambridge, UK) discusses his use of HRMS and QQQ for the analysis of the peptidome.
In this interview, Kevork Kalaydjian (ZefSci; QC, Canada) explores the changing perspectives towards cannabis and how bioanalytical scientists can help improve the understanding of the scientific benefits and limitations of cannabis and its derivatives.
In this podcast, we talk to Vibhor Gupta (Absorption Systems; PA, USA) about the importance of robust, reliable and accurate potency assays for cell and gene therapy products.